CD79A and autoimmune polyendocrinopathy: Furthermore, the task force of the 13th International Congress on APS recommended testing for IgA anti-B2GPI in patients meeting APS clinical criteria but lacking other consensus antibodies [32,33,34,35,36,37,38,39,40,41].